Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Development of a live, attenuated, recombinant vaccine for Brucellosis

Development of a live, attenuated, recombinant vaccine for Brucellosis

US Patent 7364745 · Granted Apr 29, 2008

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Multivalent Brucella vaccine for protection against mycobacterial infections and2019
Multivalent Brucella vaccine for protection against mycobacterial infections and2019
Over-expressing homologous antigen vaccine and a method of making the same2004
Over-expressing homologous antigen vaccine and a method of making the same2004
Live vaccine against Brucellosis2002
Live vaccine against Brucellosis2002
Live vaccine against Brucellosis2002
Method for protecting a mammalian host against infection by Brucella2001
Over-expressing homologous antigen vaccine and a method of making the same2000
Over-expressing homologous antigen vaccine and a method of making the same2000